As the year draws to a close, we want to extend our heartfelt thanks to everyone who has supported and helped make REAL-AD a reality — from our participants to funding bodies and beyond. Your support has been truly invaluable.

We look forward to what 2025 has in store for us and cannot wait to share the exciting things we’re working on with you. From all of us at the REAL-AD team, we wish you a joyful Christmas and a wonderful New Year!

At the CTAD (Clinical Trials on Alzheimer's Disease) conference in Madrid, held from October 29 to November 1, 2024, the study leader, Professor Michael Schöll, presented the first results from the REAL AD study.

On Wednesday, October 23rd, we organized a webinar for REAL AD participants with Professor Miia Kivipelto, a world-renowned researcher at Karolinska Institutet and a leader in dementia prevention research. We discussed with Miia what can be done to maintain brain health, as well as a major European research study in which the REAL AD team collaborates with Miia’s team.

You can access the recording via the following link: https://www.youtube.com/@REALAD24/videos

What affects your aging? Talk at the City Library in Gothenburg between two of Sweden's leading aging researchers, Miia Kivipelto, professor of clinical geriatrics at Karolinska Institutet, and Ingmar Skoog, professor of psychiatry and director of AgeCap, University of Gothenburg. Read more about the event here.

Read the article with updates on the REAL AD study here.

P4 Skaraborg reports on the study status after the first few months. You can listen here (starting at 19:52).

P4 Väst reports on the study status after the first few months. You can listen to the radio segment and the interview with Michael Schöll by clicking here. Over 5,000 people have signed up for the study so far.

Today, Michael and the team at Närhälsan Älvängen appeared on TV4 Nyheterna to talk about the study.

See the clip here here (Swedish).

AD-RIDDLE is a large European-funded project which aims to develop an online platform to improve the detection, assessment and prevention of cognitive decline and dementia. The project is led by Karolinska Institutet (Sweden) and Gates Ventures (US). The REAL AD study is part of AD-RIDDLE. We are currently setting up an Advisory Board (AB) for the project.

The AB will be composed of lay members of the public and will include older adults with and without cognitive problems interested in brain health and dementia risk reduction (e.g. people with no cognitive problems, people with Subjective Cognitive Decline or Mild Cognitive Impairment). Members of the AB will meet online regularly to discuss topics and issues relevant to the project. Members are required to be able to express themselves in English and should be willing to share their personal views, concerns and experiences. No technical or previous specific knowledge is required. The meetings will last around 2 hours and will take the form of an informal group discussion between the members of the AB and some of the researchers of the project. Members will receive information about the topic and the questions for the meeting a week prior to the meeting. Membership to the AB will be renewed on annual basis and members are expected to attend at least 3-4 meetings per year.

Are you interested in joining, or would you like to receive more information? We are happy to receive your e-mail at info@realad.se.

Michael Schöll was invited to the Swedish Brain Foundation's round table with Anna Tenje, Minister for Social Security and Elderly, to talk about the future of Alzheimer's diagnosis in Sweden.

Read the article here (Swedish).

Click here to read the printed article in Expressen (Swedish). The article was also published in Kvällsposten and GT.

Click here to read the printed article (Swedish).

Read the article here (Swedish).

Click here to read the article in Expressen.

Read the published article in Härryda-Posten here (Swedish).

Click here to read the article (in Swedish).

Read the article in Partille Tidning here (Swedish).

Watch the clip to learn more about blood tests for Alzheimer's disease why the REAL AD study is so important right now.

Read the article published in Alekuriren here (Swedish).

Listen to the interview here (Swedish).

Read the article published in Torslanda-Öckerötidningen here (in Swedish).

Listen to the interview with Professor Michael Schöll in P4 Göteborg here (from 1:39:37).

The REAL AD study has been discussed in Vetenskapsradion and has subsequently been presented as a telegram in national and local news radio stations. For example, in P1 Morgon, which you can listen to here (01:36:50, in Swedish). Or in P4 Uppland, which you can listen to here (02:36:38, in Swedish).

Professor Michael Schöll was invited and interviewed by P4 Skaraborg to talk about the REAL AD study. Listen to the radio interview here (from 1:38:40, in Swedish).

Read the article here (Swedish).

Read the article about the study in the GU (University of Gothenburg) journal here.

Göteborgs-Posten has published an article about the study, with an interview with the study leader Professor Michael Schöll. Read the article here (in Swedish).

Read the article published in Skaraborgsbygden here (in Swedish).

Read the article here (Swedish).

Early detection of Alzheimer's disease is crucial to provide effective treatment and care. Click here to listen to P4 Väst's radio interview with Professor Michael Schöll, leader of the REAL AD study, where he highlights the importance of the study.

The University of Gothenburg has published an interview with Professor Michael Schöll, click here to read the interview.

The Swedish Alzheimer's Foundation supports the REAL AD study and encourages everyone in the target group to apply!

Click here to listen to P4 Halland's radio interview with Professor Kaj Blennow, one of the researchers behind the REAL AD study.

Today we launch the REAL AD study!!! After years of preparation, we are now welcoming participants and hope that many will join us!

Read the article here (Swedish).

Läkemedelsvärlden published an interview today with Professor Michael Schöll. The article discusses, among other things, why the study is so relevant today and its details. Click here to read the article (in Swedish).

The REAL AD study will investigate the possibility of detecting Alzheimer's disease early on in primary care using new digital tools and simple blood tests. On March 12th, we had a fantastic kickoff meeting meeting where fifty key individuals gathered at Sahlgrenska Academy in Gothenburg, as well as via a link from Berlin and London.